Filter Results:
(663)
Show Results For
- All HBS Web
(663)
- People (2)
- News (225)
- Research (298)
- Events (4)
- Multimedia (12)
- Faculty Publications (179)
Show Results For
- All HBS Web
(663)
- People (2)
- News (225)
- Research (298)
- Events (4)
- Multimedia (12)
- Faculty Publications (179)
- Article
The Business of Medicine in the Era of COVID-19
By: David M. Cutler, Sayeh Nikpay and Robert S. Huckman
This Viewpoint discusses the shifting landscape of health care financing, regulation, and delivery as a result of the coronavirus pandemic, and discusses regulatory and other changes that need to be in place if telehealth and physician practice and hospital mergers... View Details
Keywords: Health Care; COVID-19; Telemedicine; Business; Health Pandemics; Health Care and Treatment; Change; Competition
Cutler, David M., Sayeh Nikpay, and Robert S. Huckman. "The Business of Medicine in the Era of COVID-19." JAMA, the Journal of the American Medical Association 323, no. 20 (May 26, 2020): 2003–2004.
- 01 May 2020
- News
The Business of Medicine in the Era of COVID-19
- July 16, 2020
- Article
How to Build a Life: Love Is Medicine for Fear
By: Arthur C. Brooks
Brooks, Arthur C. "How to Build a Life: Love Is Medicine for Fear." The Atlantic (July 16, 2020).
- June 2023
- Case
Verve Therapeutics: Taking DNA Editing to Heart
By: Shikhar Ghosh and Shweta Bagai
Verve Therapeutics, a public biotech company based in Boston, created a novel approach to addressing cardiovascular disease (CVD) - a leading cause of deaths globally. The company's approach was a single shot treatment to permanently lower cholesterol, thus reducing... View Details
Keywords: AI; Genetic Engineering; Medicine; Health Care and Treatment; Genetics; Innovation Strategy; Business and Stakeholder Relations; Medical Specialties; Innovation and Invention; Entrepreneurship; Biotechnology Industry
Ghosh, Shikhar, and Shweta Bagai. "Verve Therapeutics: Taking DNA Editing to Heart." Harvard Business School Case 823-113, June 2023.
- October 4, 2018
- Article
Precision Medicine Needs a Business Mindset in Order to Flourish
By: Richard G. Hamermesh and Kathryn E. Giusti
Hamermesh, Richard G., and Kathryn E. Giusti. "Precision Medicine Needs a Business Mindset in Order to Flourish." STAT (October 4, 2018).
- March 2008 (Revised June 2008)
- Case
The Broad Institute: Applying the Power of Genomics to Medicine
By: Vicki L. Sato and Rachel Gordon
In June 2003, Harvard University and MIT announced an unprecedented partnership to create a biomedical institute, The Broad Institute. The culture of the Broad centered on science, and those involved considered it to be at the edge of the scientific frontier. In just... View Details
Keywords: Education; Health Care and Treatment; Innovation Leadership; Growth and Development Strategy; Organizational Culture; Partners and Partnerships; Research and Development; Genetics
Sato, Vicki L., and Rachel Gordon. "The Broad Institute: Applying the Power of Genomics to Medicine." Harvard Business School Case 608-114, March 2008. (Revised June 2008.)
- 16 Feb 2011
- News
Healthy Growth
Ayers After gaining experience in strategy consulting, M&As, systems engineering, and running a multibillion-dollar refrigeration company, Jonathan Ayers (MBA ‘83) has come full circle to a job that relates to his Yale undergraduate major in molecular biophysics and... View Details
- 2021
- Working Paper
Regulatory Approval and Expanded Market Size
By: Benjamin Berger, Amitabh Chandra and Craig Garthwaite
Regulatory review of new medicines is often viewed as a hindrance to innovation by increasing the hurdle to bring products to market. However, a more complete accounting of regulation must also account for its potential market expanding effects through quality... View Details
Keywords: New Medicines; Regulatory Approval; Health Care and Treatment; Research and Development; Governing Rules, Regulations, and Reforms; Markets; Expansion; Pharmaceutical Industry
Berger, Benjamin, Amitabh Chandra, and Craig Garthwaite. "Regulatory Approval and Expanded Market Size." NBER Working Paper Series, No. 28889, June 2021.
- September 2020 (Revised February 2021)
- Case
Pricing the Priceless: Covering Transformational Medicines at Harvard Pilgrim Health Plan
By: Amitabh Chandra and Sofia Guerra
Chandra, Amitabh, and Sofia Guerra. "Pricing the Priceless: Covering Transformational Medicines at Harvard Pilgrim Health Plan." Harvard Business School Case 621-059, September 2020. (Revised February 2021.)
- Article
The Impact of Personal Genomics on Risk Perceptions and Medical Decision-Making
By: Joshua Lev Krieger, Fiona Murray, J. Scott Roberts and Robert C. Green
Krieger, Joshua Lev, Fiona Murray, J. Scott Roberts, and Robert C. Green. "The Impact of Personal Genomics on Risk Perceptions and Medical Decision-Making." Nature Biotechnology 34, no. 9 (September 2016): 912–918.
- fall 2002
- Article
Science and Medicine in Court: Expert Testimony in the German Thalidomide Trial
By: Arthur A. Daemmrich
Daemmrich, Arthur A. "Science and Medicine in Court: Expert Testimony in the German Thalidomide Trial." Chemical Heritage, no. 20 (fall 2002): 12–13, 28–33.
- Working Paper
Rebates in the Pharmaceutical Industry: Evidence from Medicines Sold in Retail Pharmacies in the U.S.
By: Pragya Kakani, Michael Chernew and Amitabh Chandra
Rising list prices are often used to illustrate the burden of prescription drug spending, but payers routinely negotiate rebates from manufacturers that generate differences between list and net prices. List prices are easily available and affect patient cost-sharing,... View Details
Keywords: Pharmaceuticals; Rebates; Health Care and Treatment; Markets; Price; Analysis; Pharmaceutical Industry
Kakani, Pragya, Michael Chernew, and Amitabh Chandra. "Rebates in the Pharmaceutical Industry: Evidence from Medicines Sold in Retail Pharmacies in the U.S." NBER Working Paper Series, No. 26846, March 2020.
- 2008
- Other Unpublished Work
Evidence-Based Medicine and the Changing Nature of Healthcare: 2007 IOM Annual Meeting Summary
Keywords: Health
Porter, Michael E. "Evidence-Based Medicine and the Changing Nature of Healthcare: 2007 IOM Annual Meeting Summary." Institute of Medicine, Washington, DC, October 2008.
- December 2022
- Article
The Contribution of Price Growth to Pharmaceutical Revenue Growth in the United States: Evidence from Medicines Sold in Retail Pharmacies
By: Pragya Kakani, Michael Chernew and Amitabh Chandra
Context: To what extent does pharmaceutical revenue growth depend on new medicines versus increasing prices for existing medicines? Moreover, does using list prices, as is commonly done, instead of prices net of confidential rebates offered by manufacturers, which are... View Details
Kakani, Pragya, Michael Chernew, and Amitabh Chandra. "The Contribution of Price Growth to Pharmaceutical Revenue Growth in the United States: Evidence from Medicines Sold in Retail Pharmacies." Journal of Health Politics, Policy and Law 47, no. 6 (December 2022): 629–648.
- March 2010 (Revised August 2012)
- Supplement
WellSpace Treatment Centers for Complementary and Alternative Medicine (B) - The Marino Center
The Marino Center provides complementary traditional and alternative health care services. It wants to grow, but how and where? View Details